{"lastClose": 22.280000686645508, "len": 1216, "date": "2023-01-04", "alpha_1": -0.147044758976559, "beta_1": 1.8628932308045139, "drawup_1": 1.483942521424141, "natr_1": 6.212332617620183, "sup_1": -0.10996415274757347, "res_1": 0.0255834113865229, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 70.68223940086509, "adx_1": 46.71167013037508, "drawdown_1": -0.5954301139589551, "stratHoldSharpe_1": 0.35946701355307203, "stratHoldAlpha_1": 251.26550349036512, "stratHoldDrawdown_1": -0.5358871025630596, "alpha_3mo": 33.806916063138594, "beta_3mo": 2.046249158665327, "drawup_3mo": 1.1882927127000764, "sharpe_3mo": 3.9182928512821458, "natr_3mo": 6.212332617620183, "sup_3mo": -0.012118540629506536, "res_3mo": 0.07854572147671376, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 79.828311424303, "adx_3mo": 42.40142920344209, "drawdown_3mo": -0.10775862220837384, "stratHoldSharpe_3mo": 4.17017181636251, "stratHoldAlpha_3mo": 254.1725909410574, "stratHoldDrawdown_3mo": -0.10038880905570102, "Market Cap": 620994666, "Industry": "Biotechnology: Pharmaceutical Preparations", "Name": "BioXcel Therapeutics Inc.", "IPO Year": 2018.0, "Sector": "Health Care", "Country": "United States", "alpha%_1": 0.5120992528419586, "beta%_1": 0.95326430383358, "drawup%_1": 0.9991475443421659, "natr%_1": 0.792229705481555, "drawdown%_1": 0.1747995739853962, "stratHoldSharpe%_1": 0.7469311060762363, "stratHoldAlpha%_1": 0.865569021883201, "stratHoldDrawdown%_1": 0.18187607462792532, "alpha%_3mo": 1.0, "beta%_3mo": 0.9742939306584963, "drawup%_3mo": 0.999999999930225, "sharpe%_3mo": 0.9391121376889675, "natr%_3mo": 0.78568474568448, "drawdown%_3mo": 0.6824890173219871, "stratHoldSharpe%_3mo": 0.9564683064608444, "stratHoldAlpha%_3mo": 0.9999978774649826, "stratHoldDrawdown%_3mo": 0.6751891030891662}